We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Proteomics International Laboratories is a biotechnology business based in Australia. Proteomics International Laboratories shares (PIQ) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Proteomics International Laboratories has a trailing 12-month revenue of around $2.8 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Best Overall Broker
Our top pick for
Best low-cost broker
| 52-week range | $0.825 - $1.35 |
|---|---|
| 50-day moving average | $1.0871 |
| 200-day moving average | $1.0697 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.039 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$1
| 1 week (2022-05-12) | 1.01% |
|---|---|
| 1 month (2022-04-22) | -10.71% |
| 3 months (2022-02-22) | -19.35% |
| 6 months (2021-11-22) | 11.11% |
| 1 year (2021-05-21) | -11.11% |
|---|---|
| 2 years (2020-05-22) | 203.03% |
| 3 years (2019-05-22) | 203.03% |
| 5 years (2017-05-22) | 589.66% |
| Revenue TTM | $2.8 million |
|---|---|
| Gross profit TTM | $1.9 million |
| Return on assets TTM | -33.75% |
| Return on equity TTM | -63.23% |
| Profit margin | -149.16% |
| Book value | 0.046 |
| Market capitalisation | $111 million |
TTM: trailing 12 months
We're not expecting Proteomics International Laboratories to pay a dividend over the next 12 months.
Over the last 12 months, Proteomics International Laboratories 's shares have ranged in value from as little as $0.825 up to $1.35. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Proteomics International Laboratories 's is 1.225. This would suggest that Proteomics International Laboratories 's shares are a little bit more volatile than the average for this exchange and represent, relatively speaking, a slightly higher risk (but potentially also market-beating returns).
Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research, analytical, and consultancy. Proteomics International Laboratories Ltd has a research agreement with the Busselton Population Medical Research Institute to enhance diagnosis and treatment of lung conditions, such as asthma and chronic obstructive pulmonary disease; the Janssen Research & Development, LLC for the research of diabetic kidney and heart disease treatment; and partnership with QIMR Berghofer Medical Research Institute for the detection of oesophageal adenocarcinoma, the primary common form of oesophageal cancer in Australia. The company was founded in 2001 and is based in Perth, Australia.
Everything we know about the OD6 Metals IPO, plus information on how to buy in.
Steps to owning and managing Winton Land shares.
Everything we know about the Summit Minerals IPO, plus information on how to buy in.
The picks and shovels approach is one way to gain exposure to the crypto market. Here is an ETF you could consider.
Everything we know about the Regener8 Resources IPO, plus information on how to buy in.
While crypto ETFs remain a relatively new concept, here is how you can invest in one of the first physically back Bitcoin ETFs.
Here is your how to guide on buying the first Ethereum backed ETF in Australia.
Everything we know about the Southern Palladium Limited IPO, plus information on how to buy in.
Everything we know about the Coolabah Metals IPO, plus information on how to buy in.
